Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Purkal JJ"'
Autor:
Cojocari D; Oncology Discovery, AbbVie, Inc., Smith BN; Department of Pediatrics; Medicine; Program in Cancer Biology, Vanderbilt University School of Medicine., Purkal JJ; Oncology Discovery, AbbVie, Inc., Arrate MP; Medicine., Huska JD; Oncology Discovery, AbbVie, Inc., Xiao Y; Oncology Discovery, AbbVie, Inc., Gorska A; Medicine., Hogdal LJ; Precision Medicine, AbbVie Inc., 1 North Waukegan Rd., North Chicago, IL 60064., Ramsey HE; Medicine; Program in Cancer Biology, Vanderbilt University School of Medicine., Boghaert ER; Oncology Discovery, AbbVie, Inc., Phillips DC; Oncology Discovery, AbbVie, Inc., Savona MR; Medicine; Program in Cancer Biology, Vanderbilt University School of Medicine; Vanderbilt-Ingram Cancer Center; Center for Immunobiology, Vanderbilt University School of Medicine, Nashville, TN 37232. michael.savona@vanderbilt.edu.
Publikováno v:
Haematologica [Haematologica] 2022 Apr 01; Vol. 107 (4), pp. 825-835. Date of Electronic Publication: 2022 Apr 01.
Autor:
Cox MC; AbbVie, 1 North Waukegan Road, North Chicago, IL, 60064-6098, USA., Mendes R; IBET, Instituto de Biologia Experimental e Tecnológica, Apartado 12, 2780-901, Oeiras, Portugal.; Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Avenida da República, 2780-157, Oeiras, Portugal., Silva F; CEDOC-FCM-NOVA, Centro de Estudos de Doenças Crónicas da Faculdade de Ciências Médicas, Universidade Nova de Lisboa, R. Câmara Pestana 6, 1150-078, Lisbon, Portugal., Mendes TF; IBET, Instituto de Biologia Experimental e Tecnológica, Apartado 12, 2780-901, Oeiras, Portugal.; Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Avenida da República, 2780-157, Oeiras, Portugal., Zelaya-Lazo A; AbbVie, 1 North Waukegan Road, North Chicago, IL, 60064-6098, USA., Halwachs K; AbbVie, 1 North Waukegan Road, North Chicago, IL, 60064-6098, USA., Purkal JJ; AbbVie, 1 North Waukegan Road, North Chicago, IL, 60064-6098, USA., Isidro IA; IBET, Instituto de Biologia Experimental e Tecnológica, Apartado 12, 2780-901, Oeiras, Portugal.; Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Avenida da República, 2780-157, Oeiras, Portugal., Félix A; CEDOC-FCM-NOVA, Centro de Estudos de Doenças Crónicas da Faculdade de Ciências Médicas, Universidade Nova de Lisboa, R. Câmara Pestana 6, 1150-078, Lisbon, Portugal.; IPOLFG, Instituto Português de Oncologia de Lisboa Francisco Gentil, R. Prof. Lima Basto, 1099-023, Lisbon, Portugal., Boghaert ER; AbbVie, 1 North Waukegan Road, North Chicago, IL, 60064-6098, USA., Brito C; IBET, Instituto de Biologia Experimental e Tecnológica, Apartado 12, 2780-901, Oeiras, Portugal. anabrito@ibet.pt.; Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Avenida da República, 2780-157, Oeiras, Portugal. anabrito@ibet.pt.; The Discoveries Centre for Regenerative and Precision Medicine, Lisbon Campus, Av. da República, 2780-157, Oeiras, Portugal. anabrito@ibet.pt.
Publikováno v:
Scientific reports [Sci Rep] 2021 Sep 17; Vol. 11 (1), pp. 18571. Date of Electronic Publication: 2021 Sep 17.
Autor:
Jin S; Oncology Discovery, AbbVie Inc., North Chicago, Illinois., Cojocari D; Oncology Discovery, AbbVie Inc., North Chicago, Illinois., Purkal JJ; Oncology Discovery, AbbVie Inc., North Chicago, Illinois., Popovic R; Genomics Research Center, AbbVie Inc., North Chicago, Illinois., Talaty NN; Drug Discovery Science and Technologies, AbbVie Inc., North Chicago, Illinois., Xiao Y; Oncology Discovery, AbbVie Inc., North Chicago, Illinois., Solomon LR; Oncology Discovery, AbbVie Inc., North Chicago, Illinois., Boghaert ER; Oncology Discovery, AbbVie Inc., North Chicago, Illinois., Leverson JD; Oncology Development, AbbVie Inc., North Chicago, Illinois., Phillips DC; Oncology Discovery, AbbVie Inc., North Chicago, Illinois. Darren.Phillips@AbbVie.com.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Jul 01; Vol. 26 (13), pp. 3371-3383. Date of Electronic Publication: 2020 Feb 13.
Autor:
Esler WP; Cardiovascular, Metabolic and Endocrine Diseases Research Unit, Pfizer Global Research and Development, Cambridge, MA 02139, USA. william.esler@pfizer.com., Tesz GJ; Cardiovascular, Metabolic and Endocrine Diseases Research Unit, Pfizer Global Research and Development, Cambridge, MA 02139, USA., Hellerstein MK; KineMed Inc., Emeryville, CA 94608, USA.; Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA 94720, USA., Beysen C; KineMed Inc., Emeryville, CA 94608, USA., Sivamani R; Department of Dermatology, School of Medicine, University of California, Davis, Davis, CA 95816, USA., Turner SM; KineMed Inc., Emeryville, CA 94608, USA., Watkins SM; Verso Biosciences, Davis, CA 95618, USA., Amor PA; Cardiovascular, Metabolic and Endocrine Diseases Research Unit, Pfizer Global Research and Development, Cambridge, MA 02139, USA., Carvajal-Gonzalez S; Cardiovascular, Metabolic and Endocrine Diseases Research Unit, Pfizer Global Research and Development, Cambridge, MA 02139, USA., Geoly FJ; Drug Safety Research and Development, Pfizer Global Research and Development, Groton, CT 06340, USA., Biddle KE; Drug Safety Research and Development, Pfizer Global Research and Development, Groton, CT 06340, USA., Purkal JJ; Cardiovascular, Metabolic and Endocrine Diseases Research Unit, Pfizer Global Research and Development, Cambridge, MA 02139, USA., Fitch M; Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA 94720, USA., Buckeridge C; Cardiovascular, Metabolic and Endocrine Diseases Research Unit, Pfizer Global Research and Development, Cambridge, MA 02139, USA., Silvia AM; Cardiovascular, Metabolic and Endocrine Diseases Research Unit, Pfizer Global Research and Development, Cambridge, MA 02139, USA., Griffith DA; Cardiovascular, Metabolic and Endocrine Diseases Research Unit, Pfizer Global Research and Development, Cambridge, MA 02139, USA., Gorgoglione M; Cardiovascular, Metabolic and Endocrine Diseases Research Unit, Pfizer Global Research and Development, Cambridge, MA 02139, USA., Hassoun L; Department of Dermatology, School of Medicine, University of California, Davis, Davis, CA 95816, USA., Bosanac SS; Department of Dermatology, School of Medicine, University of California, Davis, Davis, CA 95816, USA., Vera NB; Cardiovascular, Metabolic and Endocrine Diseases Research Unit, Pfizer Global Research and Development, Cambridge, MA 02139, USA., Rolph TP; Cardiovascular, Metabolic and Endocrine Diseases Research Unit, Pfizer Global Research and Development, Cambridge, MA 02139, USA., Pfefferkorn JA; Cardiovascular, Metabolic and Endocrine Diseases Research Unit, Pfizer Global Research and Development, Cambridge, MA 02139, USA., Sonnenberg GE; Cardiovascular, Metabolic and Endocrine Diseases Research Unit, Pfizer Global Research and Development, Cambridge, MA 02139, USA.
Publikováno v:
Science translational medicine [Sci Transl Med] 2019 May 15; Vol. 11 (492).